Sign up to save your podcasts
Or
Share Monoclonal antibody therapy for COVID-19 – Part 3
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Monoclonal antibody therapy for COVID-19 – Part 3
In Part 3 of this series on monoclonal antibody therapies for COVID-19, our expert panel continues their discussion on concerns about the efficacy and distribution of these treatment options. They respond to the FDA’s recent Emergency Use Authorization (EUA) for monoclonal antibodies.
Guest speakers:
Azra Behlim, PharmD, MBA
Senior Director
Pharmacy Sourcing and Program Services
Vizient
Stacy Lauderdale, PharmD
Senior Director
Drug Information
Vizient
Steve Rudner, PharmD, MS
Director
Pharmacy Network Contracting
Vizient
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
Show Notes:
[00:37] Identifying the right patients – best practices
[03:10] The access challenge
[05:54] Plenty of availability
[06:10] COVID vaccination and use of monoclonal antibody therapy
[06:37] Post-infusion management
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: [email protected] ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
View all episodes
By Dr. Tom Villanueva and Vizient Medical Leadership Team
4.8
2020 ratings
In Part 3 of this series on monoclonal antibody therapies for COVID-19, our expert panel continues their discussion on concerns about the efficacy and distribution of these treatment options. They respond to the FDA’s recent Emergency Use Authorization (EUA) for monoclonal antibodies.
Guest speakers:
Azra Behlim, PharmD, MBA
Senior Director
Pharmacy Sourcing and Program Services
Vizient
Stacy Lauderdale, PharmD
Senior Director
Drug Information
Vizient
Steve Rudner, PharmD, MS
Director
Pharmacy Network Contracting
Vizient
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
Show Notes:
[00:37] Identifying the right patients – best practices
[03:10] The access challenge
[05:54] Plenty of availability
[06:10] COVID vaccination and use of monoclonal antibody therapy
[06:37] Post-infusion management
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: [email protected] ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed